AZTANasdaqSpecial Industry Machinery, NECFiscal year ends September 30
Azenta, Inc.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$34.84+0.75 (+2.20%)
Close on Oct 19, 2026
- Market cap
- $1.58B
- P/E (TTM)
- –
- Dividend yield
- –
Azenta, Inc. revenue by segment
By business segment
| Revenue | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample Management Solutions | $88.29M | $81.09M | $81.43M | $86.02M | $77.62M | $79.82M | $81.14M | $85.08M | $80.67M | $74.14M | $79.01M | $81.35M | 54.8% | +13.7% |
| Multiomics | $72.89M | $63.70M | $67.22M | $73.18M | $66.24M | $63.52M | $66.30M | $66.00M | $63.62M | $62.22M | $62.72M | $61.12M | 45.2% | +10.0% |
| Core Products | $47.68M | $44.30M | $47.61M | $54.45M | $45.66M | $47.89M | $49.63M | $53.33M | $49.44M | $44.84M | $48.89M | $52.68M | 29.6% | +4.4% |
| Sample Repository Services | $40.61M | $36.79M | $33.82M | $31.56M | $31.96M | $31.93M | $31.51M | $31.75M | $31.23M | $29.29M | $30.12M | $28.68M | 25.2% | +27.1% |
| Life Sciences Products | – | – | – | – | – | – | – | – | – | – | – | $82.09M | – | – |
| Life Sciences Services | – | – | – | – | – | – | – | – | – | – | – | $90.26M | – | – |
| B Medical Systems S.a.r.l. [Member] | – | – | – | – | – | – | – | $19.24M | $28.52M | – | – | $29.42M | – | – |
| B Medical Systems | – | – | – | – | – | – | – | – | – | $22.78M | $12.59M | – | – | – |
| Operating income | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sample Management Solutions | $4.94M | $3.12M | $4.98M | $9.23M | $10.74M | $2.81M | $4.77M | $9.60M | $3.58M | -$1.46M | -$616.00K | $5.97M | -54.0% |
| Multiomics | -$348.00K | -$10.07M | -$4.36M | -$136.00K | -$3.96M | -$5.54M | -$2.31M | -$997.00K | -$592.00K | -$2.88M | -$3.26M | -$2.85M | -91.2% |
| Life Sciences Products | – | – | – | – | – | – | – | – | – | – | – | -$5.24M | – |
| Life Sciences Services | – | – | – | – | – | – | – | – | – | – | – | -$1.42M | – |
| B Medical Systems S.a.r.l. [Member] | – | – | – | – | – | – | – | -$2.02M | $1.91M | – | – | -$3.54M | – |
| B Medical Systems | – | – | – | – | – | – | – | – | – | -$1.15M | -$4.41M | – | – |
By product or service
| Revenue | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Services | $119.92M | $107.15M | $107.56M | $111.17M | $104.47M | $101.38M | $103.61M | $103.39M | $100.26M | $97.58M | $98.49M | $87.68M | 74.4% | +14.8% |
| Products | $41.26M | $37.64M | $41.08M | $48.02M | $39.39M | $41.96M | $43.83M | $47.21M | $44.03M | $38.77M | $43.71M | $72.18M | 25.6% | +4.8% |
By region
| Revenue | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $91.52M | $83.02M | $87.41M | $93.78M | $87.82M | $89.94M | $93.47M | $92.16M | $95.04M | $87.74M | $90.13M | $87.92M | 56.8% | +4.2% |
| Rest of Europe | $29.99M | $25.87M | $26.50M | $32.36M | $25.43M | $25.26M | $24.32M | $28.66M | $21.37M | $22.39M | $22.73M | $2.75M | 18.6% | +17.9% |
| China | $18.79M | $16.89M | $17.93M | $16.40M | $14.32M | $12.74M | $14.89M | $15.19M | $14.51M | $13.65M | $14.90M | $13.22M | 11.7% | +31.2% |
| United Kingdom | $12.10M | $10.40M | $9.99M | $10.35M | $9.30M | $8.01M | $7.72M | $7.82M | $8.09M | $5.63M | $5.68M | $6.72M | 7.5% | +30.1% |
| Asia Pacific (Excluding China) | $6.90M | $7.53M | – | – | $5.76M | $6.37M | – | – | – | – | – | – | 4.3% | +19.8% |
| Other | $1.89M | $1.09M | $1.13M | $855.00K | $1.23M | $1.02M | $1.38M | – | – | – | – | – | 1.2% | +53.9% |
| North America | – | – | – | – | – | – | – | – | – | $88.40M | $90.59M | $91.98M | – | – |
| Asia / Pacific / Other | – | – | – | – | – | – | – | – | – | $8.66M | $10.79M | $14.39M | – | – |
| Africa [Member] | – | – | – | – | – | – | – | $13.52M | $21.99M | $18.94M | $7.51M | $20.20M | – | – |
| Asia Pacific [Member] | – | – | $5.68M | $1.86M | $6.99M | $7.39M | $5.66M | $780.00K | $5.29M | $6.96M | $8.29M | $15.42M | – | – |
| Rest of Europe | – | – | – | – | – | – | – | – | – | $23.85M | $24.83M | – | – | – |
From the segment and revenue-disaggregation notes of Azenta's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.